3 citations
,
June 2021 in “Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512)” This review highlights phytochemicals, particularly flavonoids and phenolics, as potential supportive treatments for SARS-CoV-2 by interfering with viral proteins and providing anti-inflammatory effects; it suggests a foundation for future therapeutic and vaccine development efforts.
July 2021 in “International Journal of Research in Ayurveda and Pharmacy” This review discusses the potential of plant-synthesized secondary metabolites as natural therapeutics for COVID-19 and reports no new clinical results.
January 2022 in “Annals of Institute of Biology University of Sarajevo” This study reviewed previous research and highlights the potential of plant-derived compounds as anti-coronaviral agents, emphasizing the inhibition of viral enzymes and the need for further natural-origin antiviral investigations.
1 citations
,
May 2022 in “IntechOpen eBooks” This review discusses the repurposing of natural products for COVID-19 treatment but reports no new clinical findings, highlighting ongoing research to target host and viral mechanisms.
June 2022 in “Organic communications” This study explores potential treatments for post COVID-19 complications using natural substances through molecular docking, but reports no new clinical results and existing treatments remain limited to prophylaxis and therapeutics.